$3480
Market Overview
The global Pharmacovigilance (PV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.2% in the forecast period of 2020 to 2025 and will expected to reach USD 8412.7 million by 2025, from USD 5708 million in 2019.
The Pharmacovigilance (PV) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pharmacovigilance (PV) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Pharmacovigilance (PV) market has been segmented into Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining, etc.
Breakdown by Application, Pharmacovigilance (PV) has been segmented into Hospitals, Research Organizations, Industrial, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pharmacovigilance (PV) market presented in the report. This section sheds light on the sales growth of different regional and country-level Pharmacovigilance (PV) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pharmacovigilance (PV) market.
For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Pharmacovigilance (PV) Market Share Analysis
Pharmacovigilance (PV) competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Pharmacovigilance (PV) revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pharmacovigilance (PV) revenue and market share for each player covered in this report.
The major players covered in Pharmacovigilance (PV) are: Accenture, Capgemini, Laboratory Corporation of America Holdings, Clinquest Group B.V., ICON plc., Cognizant, iMEDGlobal, ArisGlobal, IBM Corporation, ITClinical, Wipro Ltd., Foresight Group International AG, United BioSource Corporation, BioClinica, TAKE Solutions Ltd., PAREXEL International Corporation, etc. Among other players domestic and global, Pharmacovigilance (PV) market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market segment by players, this report covers
Accenture
Capgemini
Laboratory Corporation of America Holdings
Clinquest Group B.V.
ICON plc.
Cognizant
iMEDGlobal
ArisGlobal
IBM Corporation
ITClinical
Wipro Ltd.
Foresight Group International AG
United BioSource Corporation
BioClinica
TAKE Solutions Ltd.
PAREXEL International Corporation
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)
Market segment by Type, covers:
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
Market segment by Application, can be divided into
Hospitals
Research Organizations
Industrial
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Pharmacovigilance (PV)
1.2 Classification of Pharmacovigilance (PV) by Type
1.2.1 Overview: Global Pharmacovigilance (PV) Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Pharmacovigilance (PV) Revenue Market Share by Type in 2019
1.2.3 Spontaneous Reporting
1.2.4 Intensified ADR Reporting
1.2.5 Targeted Spontaneous Reporting
1.2.6 Cohort Event Monitoring
1.2.7 EHR Mining
1.3 Global Pharmacovigilance (PV) Market by Application
1.3.1 Overview: Global Pharmacovigilance (PV) Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Hospitals
1.3.3 Research Organizations
1.3.4 Industrial
1.4 Global Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
1.5 Global Pharmacovigilance (PV) Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Pharmacovigilance (PV) Market Size by Regions (2015-2020)
1.7 Global Pharmacovigilance (PV) Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Pharmacovigilance (PV) Status and Prospect (2015-2025)
1.7.2 Europe Pharmacovigilance (PV) Status and Prospect (2015-2025)
1.7.3 Asia Pharmacovigilance (PV) Status and Prospect (2015-2025)
1.7.4 South America Pharmacovigilance (PV) Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Pharmacovigilance (PV) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Accenture
2.1.1 Accenture Details
2.1.2 Accenture Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Accenture SWOT Analysis
2.1.4 Accenture Product and Services
2.1.5 Accenture Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Capgemini
2.2.1 Capgemini Details
2.2.2 Capgemini Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Capgemini SWOT Analysis
2.2.4 Capgemini Product and Services
2.2.5 Capgemini Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Laboratory Corporation of America Holdings
2.3.1 Laboratory Corporation of America Holdings Details
2.3.2 Laboratory Corporation of America Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Laboratory Corporation of America Holdings SWOT Analysis
2.3.4 Laboratory Corporation of America Holdings Product and Services
2.3.5 Laboratory Corporation of America Holdings Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Clinquest Group B.V.
2.4.1 Clinquest Group B.V. Details
2.4.2 Clinquest Group B.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Clinquest Group B.V. SWOT Analysis
2.4.4 Clinquest Group B.V. Product and Services
2.4.5 Clinquest Group B.V. Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.5 ICON plc.
2.5.1 ICON plc. Details
2.5.2 ICON plc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 ICON plc. SWOT Analysis
2.5.4 ICON plc. Product and Services
2.5.5 ICON plc. Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cognizant
2.6.1 Cognizant Details
2.6.2 Cognizant Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Cognizant SWOT Analysis
2.6.4 Cognizant Product and Services
2.6.5 Cognizant Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.7 iMEDGlobal
2.7.1 iMEDGlobal Details
2.7.2 iMEDGlobal Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 iMEDGlobal SWOT Analysis
2.7.4 iMEDGlobal Product and Services
2.7.5 iMEDGlobal Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.8 ArisGlobal
2.8.1 ArisGlobal Details
2.8.2 ArisGlobal Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 ArisGlobal SWOT Analysis
2.8.4 ArisGlobal Product and Services
2.8.5 ArisGlobal Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.9 IBM Corporation
2.9.1 IBM Corporation Details
2.9.2 IBM Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 IBM Corporation SWOT Analysis
2.9.4 IBM Corporation Product and Services
2.9.5 IBM Corporation Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.10 ITClinical
2.10.1 ITClinical Details
2.10.2 ITClinical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 ITClinical SWOT Analysis
2.10.4 ITClinical Product and Services
2.10.5 ITClinical Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.11 Wipro Ltd.
2.11.1 Wipro Ltd. Details
2.11.2 Wipro Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Wipro Ltd. SWOT Analysis
2.11.4 Wipro Ltd. Product and Services
2.11.5 Wipro Ltd. Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.12 Foresight Group International AG
2.12.1 Foresight Group International AG Details
2.12.2 Foresight Group International AG Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Foresight Group International AG SWOT Analysis
2.12.4 Foresight Group International AG Product and Services
2.12.5 Foresight Group International AG Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.13 United BioSource Corporation
2.13.1 United BioSource Corporation Details
2.13.2 United BioSource Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 United BioSource Corporation SWOT Analysis
2.13.4 United BioSource Corporation Product and Services
2.13.5 United BioSource Corporation Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.14 BioClinica
2.14.1 BioClinica Details
2.14.2 BioClinica Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 BioClinica SWOT Analysis
2.14.4 BioClinica Product and Services
2.14.5 BioClinica Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.15 TAKE Solutions Ltd.
2.15.1 TAKE Solutions Ltd. Details
2.15.2 TAKE Solutions Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 TAKE Solutions Ltd. SWOT Analysis
2.15.4 TAKE Solutions Ltd. Product and Services
2.15.5 TAKE Solutions Ltd. Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
2.16 PAREXEL International Corporation
2.16.1 PAREXEL International Corporation Details
2.16.2 PAREXEL International Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 PAREXEL International Corporation SWOT Analysis
2.16.4 PAREXEL International Corporation Product and Services
2.16.5 PAREXEL International Corporation Pharmacovigilance (PV) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pharmacovigilance (PV) Market Size by Players (2015-2020)
3.2 United States Pharmacovigilance (PV) Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Pharmacovigilance (PV) Players Market Share
3.3.2 Top 10 Pharmacovigilance (PV) Players Market Share
4 North America Market Size and Forecast by Countries
4.1 North America Pharmacovigilance (PV) Market Size by Countries (2015-2020)
4.2 North America Pharmacovigilance (PV) Market Size and Forecast by Countries (2015-2026)
4.3 United States Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
4.4 Canada Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
4.5 Mexico Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
5 Europe Market Size and Forecast by Countries
5.1 Europe Pharmacovigilance (PV) Market Size by Countries (2015-2020)
5.2 Europe Pharmacovigilance (PV) Market Size and Forecast by Countries (2015-2026)
5.3 Germany Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
5.4 France Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
5.5 UK Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
5.6 Russia Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
5.7 Italy Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Pharmacovigilance (PV) Market Size by Regions (2015-2020)
6.2 Asia-Pacific Pharmacovigilance (PV) Market Size and Forecast by Regions (2015-2026)
6.3 China Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
6.4 Japan Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
6.5 Korea Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
6.6 India Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
6.7 Southeast Asia Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
7 South America Market Size and Forecast by Countries
7.1 South America Pharmacovigilance (PV) Market Size by Countries (2015-2020)
7.2 South America Pharmacovigilance (PV) Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
7.4 Argentina Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Pharmacovigilance (PV) Revenue by Regions (2015-2020)
8.2 Middle East & Africa Pharmacovigilance (PV) Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
8.4 UAE Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
8.5 Egypt Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
8.6 South Africa Pharmacovigilance (PV) Market Size and Forecast (2015-2025)
9 Market Size Segment by Type
9.1 Global Pharmacovigilance (PV) Market Size and Forecast by Type (2015-2025)
9.1.1 Global Pharmacovigilance (PV) Market Size by Type (2015-2020)
9.1.2 Global Pharmacovigilance (PV) Market Size Forecast by Type (2020-2025)
9.2 United States Pharmacovigilance (PV) Market Size and Forecast by Type (2015-2025)
9.2.1 United States Pharmacovigilance (PV) Market Size by Type (2015-2020)
9.2.2 United States Pharmacovigilance (PV) Market Size Forecast by Type (2020-2025)
10 Market Size Segment by Application
10.1 Global Pharmacovigilance (PV) Market Size and Forecast by Application (2015-2025)
10.1.1 Global Pharmacovigilance (PV) Market Size by Application (2015-2020)
10.1.2 Global Pharmacovigilance (PV) Market Size Forecast by Application (2020-2025)
10.2 United States Pharmacovigilance (PV) Market Size and Forecast by Application (2015-2025)
10.2.1 United States Pharmacovigilance (PV) Market Size by Application (2015-2020)
10.2.2 United States Pharmacovigilance (PV) Market Size Forecast by Application (2020-2025)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US
List of Tables
Table 1. Global Pharmacovigilance (PV) Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Pharmacovigilance (PV) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pharmacovigilance (PV) Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Pharmacovigilance (PV) Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Pharmacovigilance (PV) Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Pharmacovigilance (PV) Revenue Share by Regions (2015-2020)
Table 7. Global Pharmacovigilance (PV) Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Pharmacovigilance (PV) Revenue Market Share by Regions (2020-2025)
Table 9. Accenture Corporate Information, Location and Competitors
Table 10. Accenture Major Business
Table 11. Accenture Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 12. Accenture SWOT Analysis
Table 13. Accenture Pharmacovigilance (PV) Product and Solutions
Table 14. Accenture Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. Capgemini Corporate Information, Location and Competitors
Table 16. Capgemini Major Business
Table 17. Capgemini Pharmacovigilance (PV) Total Revenue (USD Million) (2018-2019)
Table 18. Capgemini SWOT Analysis
Table 19. Capgemini Pharmacovigilance (PV) Product and Solutions
Table 20. Capgemini Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. Laboratory Corporation of America Holdings Corporate Information, Location and Competitors
Table 22. Laboratory Corporation of America Holdings Major Business
Table 23. Laboratory Corporation of America Holdings Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 24. Laboratory Corporation of America Holdings SWOT Analysis
Table 25. Laboratory Corporation of America Holdings Pharmacovigilance (PV) Product and Solutions
Table 26. Laboratory Corporation of America Holdings Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. Clinquest Group B.V. Corporate Information, Location and Competitors
Table 28. Clinquest Group B.V. Major Business
Table 29. Clinquest Group B.V. Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 30. Clinquest Group B.V. SWOT Analysis
Table 31. Clinquest Group B.V. Pharmacovigilance (PV) Product and Solutions
Table 32. Clinquest Group B.V. Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. ICON plc. Corporate Information, Location and Competitors
Table 34. ICON plc. Major Business
Table 35. ICON plc. Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 36. ICON plc. SWOT Analysis
Table 37. ICON plc. Pharmacovigilance (PV) Product and Solutions
Table 38. ICON plc. Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. Cognizant Corporate Information, Location and Competitors
Table 40. Cognizant Major Business
Table 41. Cognizant Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 42. Cognizant SWOT Analysis
Table 43. Cognizant Pharmacovigilance (PV) Product and Solutions
Table 44. Cognizant Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. iMEDGlobal Corporate Information, Location and Competitors
Table 46. iMEDGlobal Major Business
Table 47. iMEDGlobal Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 48. iMEDGlobal SWOT Analysis
Table 49. iMEDGlobal Pharmacovigilance (PV) Product and Solutions
Table 50. iMEDGlobal Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 51. ArisGlobal Corporate Information, Location and Competitors
Table 52. ArisGlobal Major Business
Table 53. ArisGlobal Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 54. ArisGlobal SWOT Analysis
Table 55. ArisGlobal Pharmacovigilance (PV) Product and Solutions
Table 56. ArisGlobal Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 57. IBM Corporation Corporate Information, Location and Competitors
Table 58. IBM Corporation Major Business
Table 59. IBM Corporation Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 60. IBM Corporation SWOT Analysis
Table 61. IBM Corporation Pharmacovigilance (PV) Product and Solutions
Table 62. IBM Corporation Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 63. ITClinical Corporate Information, Location and Competitors
Table 64. ITClinical Major Business
Table 65. ITClinical Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 66. ITClinical SWOT Analysis
Table 67. ITClinical Pharmacovigilance (PV) Product and Solutions
Table 68. ITClinical Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 69. Wipro Ltd. Corporate Information, Location and Competitors
Table 70. Wipro Ltd. Major Business
Table 71. Wipro Ltd. Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 72. Wipro Ltd. SWOT Analysis
Table 73. Wipro Ltd. Pharmacovigilance (PV) Product and Solutions
Table 74. Wipro Ltd. Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 75. Foresight Group International AG Corporate Information, Location and Competitors
Table 76. Foresight Group International AG Major Business
Table 77. Foresight Group International AG Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 78. Foresight Group International AG SWOT Analysis
Table 79. Foresight Group International AG Pharmacovigilance (PV) Product and Solutions
Table 80. Foresight Group International AG Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 81. United BioSource Corporation Corporate Information, Location and Competitors
Table 82. United BioSource Corporation Major Business
Table 83. United BioSource Corporation Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 84. United BioSource Corporation SWOT Analysis
Table 85. United BioSource Corporation Pharmacovigilance (PV) Product and Solutions
Table 86. United BioSource Corporation Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 87. BioClinica Corporate Information, Location and Competitors
Table 88. BioClinica Major Business
Table 89. BioClinica Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 90. BioClinica SWOT Analysis
Table 91. BioClinica Pharmacovigilance (PV) Product and Solutions
Table 92. BioClinica Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 93. TAKE Solutions Ltd. Corporate Information, Location and Competitors
Table 94. TAKE Solutions Ltd. Major Business
Table 95. TAKE Solutions Ltd. Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 96. TAKE Solutions Ltd. SWOT Analysis
Table 97. TAKE Solutions Ltd. Pharmacovigilance (PV) Product and Solutions
Table 98. TAKE Solutions Ltd. Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 99. PAREXEL International Corporation Corporate Information, Location and Competitors
Table 100. PAREXEL International Corporation Major Business
Table 101. PAREXEL International Corporation Pharmacovigilance (PV) Total Revenue (USD Million) (2017-2018)
Table 102. PAREXEL International Corporation SWOT Analysis
Table 103. PAREXEL International Corporation Pharmacovigilance (PV) Product and Solutions
Table 104. PAREXEL International Corporation Pharmacovigilance (PV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 105. Global Pharmacovigilance (PV) Revenue (USD Million) by Players (2015-2020)
Table 106. Global Pharmacovigilance (PV) Revenue Share by Players (2015-2020)
Table 107. Key Players Pharmacovigilance (PV) Revenue (USD Million) in United States (2015-2020)
Table 108. Key Players Pharmacovigilance (PV) Revenue Share in United States (2015-2020)
Table 109. North America Pharmacovigilance (PV) Revenue (USD Million) by Countries (2015-2020)
Table 110. North America Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
Table 111. North America Pharmacovigilance (PV) Revenue (USD Million) by Countries (2020-2026)
Table 112. North America Pharmacovigilance (PV) Revenue Market Share by Countries (2020-2026)
Table 113. Europe Pharmacovigilance (PV) Revenue (USD Million) by Countries (2015-2020)
Table 114. Europe Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
Table 115. Europe Pharmacovigilance (PV) Revenue (USD Million) by Countries (2020-2026)
Table 116. Europe Pharmacovigilance (PV) Revenue Market Share by Countries (2020-2026)
Table 117. Asia-Pacific Pharmacovigilance (PV) Revenue (USD Million) by Countries (2015-2020)
Table 118. Asia-Pacific Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
Table 119. Asia-Pacific Pharmacovigilance (PV) Revenue (USD Million) by Countries (2020-2026)
Table 120. Asia-Pacific Pharmacovigilance (PV) Revenue Market Share by Countries (2020-2026)
Table 121. South America Pharmacovigilance (PV) Revenue (USD Million) by Countries (2015-2020)
Table 122. South America Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
Table 123. South America Pharmacovigilance (PV) Revenue (USD Million) by Countries (2020-2026)
Table 124. South America Pharmacovigilance (PV) Revenue Market Share by Countries (2020-2026)
Table 125. Middle East & Africa Pharmacovigilance (PV) Revenue (USD Million) by Countries (2015-2020)
Table 126. Middle East & Africa Pharmacovigilance (PV) Revenue Market Share by Countries (2015-2020)
Table 127. Middle East & Africa Pharmacovigilance (PV) Revenue (USD Million) by Countries (2020-2026)
Table 128. Middle East & Africa Pharmacovigilance (PV) Revenue Market Share by Countries (2020-2026)
Table 129. Global Pharmacovigilance (PV) Revenue (USD Million) by Type (2015-2020)
Table 130. Global Pharmacovigilance (PV) Revenue Share by Type (2015-2020)
Table 131. Global Pharmacovigilance (PV) Revenue Forecast by Type (2020-2025)
Table 132. Global Pharmacovigilance (PV) Market Share Forecast by Type (2020-2025)
Table 133. United States Pharmacovigilance (PV) Revenue (USD Million) by Type (2015-2020)
Table 134. United States Pharmacovigilance (PV) Revenue Share by Type (2015-2020)
Table 135. United States Pharmacovigilance (PV) Revenue Forecast by Type (2020-2025)
Table 136. United States Pharmacovigilance (PV) Market Share Forecast by Type (2020-2025)
Table 137. Global Pharmacovigilance (PV) Revenue (USD Million) by Application (2015-2020)
Table 138. Global Pharmacovigilance (PV) Revenue Share by Application (2015-2020)
Table 139. Global Pharmacovigilance (PV) Revenue Forecast by Application (2020-2025)
Table 140. Global Pharmacovigilance (PV) Market Share Forecast by Application (2020-2025)
Table 141. United States Pharmacovigilance (PV) Revenue (USD Million) by Application (2015-2020)
Table 142. United States Pharmacovigilance (PV) Revenue Share by Application (2015-2020)
Table 143. United States Pharmacovigilance (PV) Revenue Forecast by Application (2020-2025)
Table 144. United States Pharmacovigilance (PV) Market Share Forecast by Application (2020-2025)
List of Figures
Figure 1. Pharmacovigilance (PV) Picture
Figure 2. Global Pharmacovigilance (PV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global Pharmacovigilance (PV) Revenue Market Share by Type in 2019
Figure 4. Spontaneous Reporting Picture
Figure 5. Intensified ADR Reporting Picture
Figure 6. Targeted Spontaneous Reporting Picture
Figure 7. Cohort Event Monitoring Picture
Figure 8. EHR Mining Picture
Figure 9. Pharmacovigilance (PV) Revenue Market Share by Application in 2019
Figure 10. Hospitals Picture
Figure 11. Research Organizations Picture
Figure 12. Industrial Picture
Figure 13. Global Pharmacovigilance (PV) Revenue and Growth Rate (2015-2025) (USD Million)
Figure 14. Global Pharmacovigilance (PV) Market Size Share by Regions (2015-2025)
Figure 15. Global Pharmacovigilance (PV) Market Size Share by Regions in 2019
Figure 16. Global Pharmacovigilance (PV) Revenue Market Share by Regions (2020-2025)
Figure 17. North America Pharmacovigilance (PV) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 18. Europe Pharmacovigilance (PV) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Pharmacovigilance (PV) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 20. South America Pharmacovigilance (PV) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 21. Middle East & Africa Pharmacovigilance (PV) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 22. Global Pharmacovigilance (PV) Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Pharmacovigilance (PV) Revenue Market Share in 2019
Figure 24. Top 10 Players Pharmacovigilance (PV) Revenue Market Share in Global Market in 2019
Figure 25. Global Pharmacovigilance (PV) Market Size (USD Million) by Type (2015-2025)
Figure 26. Global Pharmacovigilance (PV) Market Size Share by Application (2015-2025)
Figure 27. North America Pharmacovigilance (PV) Market Size Share by Countries (2015-2025)
Figure 28. North America Pharmacovigilance (PV) Market Size Share by Countries in 2019
Figure 29. United States Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 30. Canada Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 31. Mexico Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 32. Europe Pharmacovigilance (PV) Market Size Share by Countries (2015-2025)
Figure 33. Europe Pharmacovigilance (PV) Market Size Share by Countries in 2019
Figure 34. Germany Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 35. France Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 36. Russia Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 37. Italy Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 38. Spain Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 39. UK Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 40. Asia Pharmacovigilance (PV) Market Size Share by Countries (2015-2025)
Figure 41. Asia Pharmacovigilance (PV) Market Size Share by Countries in 2019
Figure 42. China Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 43. Japan Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 44. Korea Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 45. India Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 46. Southeast Asia Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 47. South America Pharmacovigilance (PV) Market Size Share by Countries (2015-2025)
Figure 48. South America Pharmacovigilance (PV) Market Size Share by Countries in 2019
Figure 49. Brazil Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 50. Argentina Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 51. Middle East & Africa Pharmacovigilance (PV) Market Size Share by Countries (2015-2025)
Figure 52. Middle East & Africa Pharmacovigilance (PV) Market Size Share by Countries in 2019
Figure 53. Saudi Arabia Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 54. UAE Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 55. Egypt Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 56. South Africa Pharmacovigilance (PV) Market Size (USD Million) and Forecast (2015-2025)
Figure 57. Global Pharmacovigilance (PV) Revenue Share by Type (2015-2020)
Figure 58. United States Pharmacovigilance (PV) Revenue Share by Type (2015-2020)
Figure 59. Global Pharmacovigilance (PV) Revenue Share by Application (2015-2020)
Figure 60. United States Pharmacovigilance (PV) Revenue Share by Application (2015-2020)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –
Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance
Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.
Dear Siddhartha, The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us. Thanks for all your help!
Hi Siddhartha-san, Many thanks for sending trade map with final report. Best regards,
Hello Sapna,
Thanks for the report. We've been going through it and see some good data on the market and players.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.
IND